Access the full text.
Sign up today, get DeepDyve free for 14 days.
Guillemette Thomas, J. Mancini, N. Jourde-Chiche, G. Sarlon, Z. Amoura, J. Harlé, E. Jougla, L. Chiche (2014)
Mortality Associated With Systemic Lupus Erythematosus in France Assessed by Multiple‐Cause‐of‐Death AnalysisArthritis & Rheumatology, 66
S. Shinjo, E. Bonfá, D. Wojdyla, E. Borba, L. Ramírez, H. Scherbarth, J. Brenol, R. Chacón-díaz, O. Neira, G. Berbotto, I. Torre, E. Acevedo-Vázquez, L. Massardo, L. Barile-fabris, F. Caeiro, L. Silveira, E. Sato, Sandra Buliubasich, G. Alarcón, B. Pons-Estel (2010)
Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.Arthritis and rheumatism, 62 3
M. Yurkovich, Kateryna Vostretsova, Wenjia Chen, J. Aviña-Zubieta (2014)
Overall and Cause‐Specific Mortality in Patients With Systemic Lupus Erythematosus: A Meta‐Analysis of Observational StudiesArthritis Care & Research, 66
C. Yee, Li Su, V. Toescu, R. Hickman, D. Situnayake, S. Bowman, V. Farewell, C. Gordon (2015)
Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years.Rheumatology, 54 5
K. Lerang, I. Gilboe, D. Thelle, J. Gran (2014)
Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort studyLupus, 23
J. Merola, B. Bermas, B. Lu, E. Karlson, E. Massarotti, PH Schur, K. Costenbader (2014)
Clinical manifestations and survival among adults with (SLE) according to age at diagnosisLupus, 23
RW Telles, CCD Lanna, RCP Reis, FL Sousa, LA Rodrigues, AL Ribeiro (2010)
Causes and predictors of death in 181 Brazilian patients with systemic lupusArthritis Rheum, 62
César Nieves, P. Izmirly (2016)
Mortality in Systemic Lupus Erythematosus: an Updated ReviewCurrent Rheumatology Reports, 18
C. Bartels, K. Buhr, J. Goldberg, C. Bell, Maja Visekruna, Swapna Nekkanti, R. Greenlee (2014)
Mortality and Cardiovascular Burden of Systemic Lupus Erythematosus in a US Population-based CohortThe Journal of Rheumatology, 41
G. Ruiz‐Irastorza, M. Egurbide, J. Pijoan, M. Garmendia, I. Villar, A. Martínez-Berriotxoa, J. Erdozain, C. Aguirre (2006)
Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosusLupus, 15
D. Gladman, E. Ginzler, C. Goldsmith, P. Fortin, Matthew Liang, J. Sánchez-Guerrero, M. Urowitz, P. Bacon, S. Bombardieri, J. Hanly, John Jones, E. Hay, D. Symmons, D. Isenberg, Kenneth Kalunion, P. Maddison, O. Nived, G. Sturfelt, M. Petri, Martin Richter, M. Snaith, A. Zoma (1996)
The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.Arthritis and rheumatism, 39 3
Ziqian Wang, Yanhong Wang, R. Zhu, X. Tian, Dong Xu, Qian Wang, Chanyuan Wu, Shangzhu Zhang, Jiuliang Zhao, Yan Zhao, Mengtao Li, Xiaofeng Zeng (2015)
Long-Term Survival and Death Causes of Systemic Lupus Erythematosus in ChinaMedicine, 94
O. Barrett, E. Abramovich, J. Dreiher, V. Novack, M. Abu-Shakra (2014)
Mortality due to sepsis in patients with systemic lupus erythematosus and rheumatoid arthritis.The Israel Medical Association journal : IMAJ, 16 10
L. González, S. Toloza, G. Alarcón (2014)
Impact of race and ethnicity in the course and outcome of systemic lupus erythematosus.Rheumatic diseases clinics of North America, 40 3
R. Telles, C. Lanna, F. Souza, L. Rodrigues, R. Reis, A. Ribeiro (2013)
Causes and predictors of death in Brazilian lupus patientsRheumatology International, 33
Y. Lee, S. Choi, J. Ji, G. Song (2016)
Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysisLupus, 25
Crl Cardoso, FV Signorelli, Jas Papi, G.R.D. Salles (2008)
Initial and accrued damage as predictors of mortality in Brazilian patients with systemic lupus erythematosus: a cohort studyLupus, 17
S. Wadee, M. Tikly, M. Hopley (2007)
Causes and predictors of death in South Africans with systemic lupus erythematosus.Rheumatology, 46 9
G. Ruiz‐Irastorza, M. Egurbide, J. Ugalde, C. Aguirre (2004)
High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.Archives of internal medicine, 164 1
JF Merola, B Bermas, B Lu, E Karlson, E Massarotti, PH Schur (2014)
Clinical manifestations and survival among adults with systemic lupus erythematosus according to age at diagnosis HHS public accessLupus, 23
M. Ugarte-Gil, G. Pons-Estel, J. Molineros, D. Wojdyla, G. McGwin, S. Nath, B. Pons-Estel, M. Alarcón-Riquelme, G. Alarcón (2015)
Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary.Rheumatology, 55 3
G. Alarcón, G. McGwin, A. Bertoli, B. Fessler, J. Calvo-Alén, H. Bastian, L. Vilá, J. Reveille (2007)
Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)Annals of the Rheumatic Diseases, 66
J. Gómez-Puerta, R. Cervera (2014)
Diagnosis and classification of the antiphospholipid syndrome.Journal of autoimmunity, 48-49
C. Vitali, S. Bombardieri, R. Jonsson, H. Moutsopoulos, E. Alexander, S. Carsons, T. Daniels, P. Fox, Robert Fox, S. Kassan, S. Pillemer, N. Talal, M. Weisman (2002)
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus GroupAnnals of the Rheumatic Diseases, 61
Z Wang, Y Wang, R Zhu, X Tian, D Xu, Q Wang (2015)
Long-term survival and death causes of systemic lupus erythematosus in China a systemic review of observational studiesBaltimore (Medicine), 94
D. Souza, A. Santo, E. Sato (2012)
Mortality Profile Related to Systemic Lupus Erythematosus: A Multiple Cause-of-death AnalysisThe Journal of Rheumatology, 39
F. Rees, M. Doherty, M. Grainge, P. Lanyon, G. Davenport, Weiya Zhang (2016)
Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012.Rheumatology, 55 5
A. Voss, H. Laustrup, J. Hjelmborg, P. Junker (2013)
Survival in systemic lupus erythematosus, 1995–2010. A prospective study in a Danish communityLupus, 22
J. Cui, S. Saevarsdottir, Brian Thomson, L. Padyukov, A. Mil, J. Nititham, L. Hughes, N. Vries, S. Raychaudhuri, L. Alfredsson, J. Askling, S. Wedrén, B. Ding, C. Guiducci, G. Wolbink, J. Crusius, I. Horst-Bruinsma, M. Herenius, M. Weinblatt, N. Shadick, Jane Worthington, F. Batliwalla, M. Kern, A. Morgan, A. Wilson, J. Isaacs, K. Hyrich, M. Seldin, L. Moreland, T. Behrens, C. Allaart, L. Criswell, T. Huizinga, P. Tak, S. Bridges, R. Toes, A. Barton, L. Klareskog, P. Gregersen, E. Karlson, R. Plenge (2010)
Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy.Arthritis and rheumatism, 62 7
C. Bombardier, D. Gladman, M. Urowitz, Dominique Caron, Chih Chang, A. Austin, A. Bell, D. Bloch, Paul Corey, J. Decker, J. Esdaile, J. Fries, E. Ginzler, C. Goldsmith, M. Hochberg, John Jones, Nicole Riche, M. Liang, M. Lockshin, L. Muenz, D. Sackett, P. Schur (1992)
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.Arthritis and rheumatism, 35 6
Mph Hochberg (1997)
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis and rheumatism, 40 9
Systemic lupus erythematosus (SLE) treatments progress over the years. However, the mortality remains higher than in the general population. Few studies have examined SLE patients’ survival in Brazil. This study aims to identify the main characteristics and risk factors to predict mortality and recognize the main causes of death in Brazilian patients with SLE. We retrospectively assessed clinical, demographic, and serological characteristics from 600 patients followed since 2001 in SLE outpatient clinic from Hospital de Clínicas de Porto Alegre. Risk factors for mortality were examined by univariate and multivariate Cox proportional hazards regression analyses. A p < 0.05 was considered significant. There were 527 survivors (87.83%). The main causes of death were cardiovascular disease (17%), infection (17%), and infection and SLE activity (17%). Risk factors for death were age at diagnosis (HR 1.065, CI 95% 1.039–10.092), SLICC damage index (HR 1.299, CI 95% 1.076–1569), antiphospholip syndrome (HR 3.021, CI 95% 1.307–6.985), and metilprednisolone pulse (HR 2.628, CI 95% 1.283–5.383). Antimalarials was a protective factor for death (HR 0.191, CI 95% 0.064–0.570). Cardiovascular disease, infection, and SLE activity associated with infection were the main known causes of deaths in our SLE patients. Secondary antiphospolipid syndrome, highest score in SLICC damage index, advanced age at diagnosis, and high dose of corticosteroids were risk factors for mortality. Antimalarials was an important protective factor.
Clinical Rheumatology – Springer Journals
Published: Jun 26, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.